Literature DB >> 5426953

The enzymatic reduction of hydroxyurea to urea by mouse liver.

M Colvin, V H Bono.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5426953

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

Review 1.  Pharmacokinetics and pharmacodynamics of hydroxyurea.

Authors:  P R Gwilt; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

2.  [Studies on synchronisation in vivo: temporary inhibition of DNA synthesis in normal and malignant mammalian cell systems with hydroxyurea].

Authors:  M F Rajewsky; D F Hülser; E Fabricius
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

3.  Population pharmacokinetics of hydroxyurea in cancer patients.

Authors:  W G Tracewell; D L Trump; W P Vaughan; D C Smith; P R Gwilt
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics.

Authors:  Aisha L Walker; Cynthia S Lancaster; David Finkelstein; Russell E Ware; Alex Sparreboom
Journal:  Am J Physiol Cell Physiol       Date:  2013-08-28       Impact factor: 4.249

5.  Tolerability and age-dependent toxicokinetics following perinatal hydroxyurea treatment in Sprague Dawley rats.

Authors:  Madelyn C Huang; Katie J Turner; Molly Vallant; Veronica G Robinson; Yi Lu; Catherine J Price; Timothy R Fennell; Melanie A Silinski; Suramya Waidyanatha; Kristen R Ryan; Sherry R Black; Reshan A Fernando; Barry S McIntyre
Journal:  J Appl Toxicol       Date:  2020-11-25       Impact factor: 3.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.